The announcement that Omega has agreed a manufacturing contract with the UK Government to produce lateral flow antigen tests, as part of its plans to control the spread of the coronavirus, is a significant endorsement of Omega’s capabilities and competencies, as the government seemingly seeks to ensure the security of supply of such tests from within the UK. We have adjusted FY 2021 forecasts downwards to reflect the concomitant trading update, which highlights a c.£3.3m shortfall in revenues, l ....
11 Feb 2021
Omega Diagnostics - Government contract and trading update
Sign up to access
Get access to our full offering from over 30 providers
Get access to our full offering from over 30 providers
Omega Diagnostics - Government contract and trading update
Cambridge Nutritional Sciences PLC (CNSL:LON) | 3.2 0 0.0% | Mkt Cap: 7.73m
- Published:
11 Feb 2021 -
Author:
Mark Brewer | Cavendish Research -
Pages:
10
The announcement that Omega has agreed a manufacturing contract with the UK Government to produce lateral flow antigen tests, as part of its plans to control the spread of the coronavirus, is a significant endorsement of Omega’s capabilities and competencies, as the government seemingly seeks to ensure the security of supply of such tests from within the UK. We have adjusted FY 2021 forecasts downwards to reflect the concomitant trading update, which highlights a c.£3.3m shortfall in revenues, l ....